Quantity of suitable people: CDEC talked over the uncertainty in the quantity of sufferers with reasonably critical to significant hemophilia B in Canada suitable for etranacogene dezaparvovec. Clinical specialists consulted by CADTH indicated that some people who're categorized as having gentle or reasonable disease could possibly have a serious b